Effect of preparation technique on the properties and in vivo efficacy of benzocaine-loaded ethosomes

Journal of Liposome Research

Volumn 19, Issue 4, 2009, Pages 253-260

  Maestrelli, Francesca ^a   Capasso, Gaetano ^a   González Rodríguez, Maria L ^b   Rabasco, Antonio M ^b   Ghelardini, Carla ^a   Mura, Paola ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Benzocaine; Ethosomes; FATMLV; In vivo anesthetic efficacy; LUV; MLV; SUV

Indexed keywords

BENZOCAINE; ETHOSOME; LIPOSOME; UNCLASSIFIED DRUG;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; IN VITRO STUDY; IN VIVO STUDY; LIPOPHILICITY; MALE; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANESTHETICS, LOCAL; ANIMALS; BENZOCAINE; DRUG STABILITY; LIPOSOMES; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; RABBITS;

EID: 70350755794     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982100902788408     Document Type: Article

References (29)

1. Bangham AD, Standish MM, Watkins JC. (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238-252.
2. Barclay L, Vega C. (2004). Methahemoglobinaemia linked to topical benzocaine use. Arch Intern Med 164:1192-1195.
3. Dayan N, Touitou E. (2000). Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 21:1879-1885.
4. Dubey V, Mishra D, Dutta T, Nahar M, Saraf DK, Jain NK. (2007). Dermal and transdermal delivery of an antipsoriatic agent via ethanolic liposomes. J Contr Rel 123:148-154.
5. Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM. (2006). Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. Int J Pharm 322:60-66.
6. Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM. (2007). Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen. Pharmazie 62:133-137.
7. Esposito E, Menegatti E, Cortesi R. (2004). Ethosomes and liposomes as topical vehicles for azelaic acid: a preformulation study. J Cosmet Sci 53:253-264.
8. Fang J, Hwang T, Huang Y, Fang C. (2006). Enhancement of transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol. Int J Pharm 310:131-138.
9. Ghelardini C, Galeotti N, Di Cesare Mannelli L, Mazzanti G, Bartolini A. (2001). Local anaesthetic activity of β-caryophyllene. Il Farmaco 56:387-389.
10. Godin B, Touitou E. (2003) Ethosomes: new prospects in transdermal delivery. Crit Rev Ther Drug Carrier Syst 20:63-102.
11. Grant GJ, Bansinath M. (2001). Liposomal delivery systems for local anaesthetics. Reg Anesth Pain Med 26:61-63.
12. Gregoriadis G. (2000). Liposome Technology, 2nd ed, Vol.I-III. Boca Raton, Florida, USA: CRC Press.
13. Kane GC, Hoehn SM, Behrenbeck TR, Mulvagh SL. (2007). Benzocaine-induced metha-hemoglobinemia based on the Mayo Clinic experience from transesophageal echocardiograms: incidence, outcomes, and predisposing factors. Arch Intern Med 167:1977-1982.
14. Lim JO, Kim SJ, Pouliot R, Baek WY. (2005). Enhanced transdermal delivery of local anesthetics by liposome formulation of local anesthetic mixture. Key Eng Mater 277:45-50.
15. López-Pinto JM, González-Rodríguez ML, Rabasco AM. (2005). Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm 298:1-12.
16. Maestrelli F, González-Rodríguez ML, Rabasco AM, Mura P. (2005). Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery. Int J Pharm 298:55-67.
17. Maestrelli F, González-Rodríguez ML, Rabasco AM, Mura P. (2006). Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery. Int J Pharm 312:53-60.
18. Manosroi A, Kongkaneramit LL, Manosroi J. (2004). Characterization of amphotericin B liposome formulation. Drug Dev Ind Pharm 30:535-543.
19. Mayer LD, Hope MJ, Cullis PR, Janoff AS. (1985). Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles. Biochim Biophys Acta 817:193-196.
20. Moffat AC, Osselton MD, Widdop B. (2004). Clarke's Analysis of Drugs and Poisons, 3rd ed. London: Pharmaceutical Press.
21. Mura P, Maestrelli F, González-Rodríguez ML, Michelacci I, Ghelardini C, Rabasco AM. (2007). Development, characterization, and in vivo evaluation of benzocaine-loaded liposome. Eur J Pharm Sci 67:86-95.
22. Mura P, Capasso G, Maestrelli F, Furlanetto S. (2008). Optimization of formulation variables of benzocaine liposomes using experimental design. J Lipos Res 18:1-13.
23. Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M. (2005). Ethosomes for skin delivery of ammonium glycyrrhizinate: In vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Contr Rel 106:99-110.
24. Szoka F. (1978). Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci U S A 75:4194-4198.
25. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. (2000). Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Contr Rel 65:403-418.
26. Trotta M, Peira E, Carlotti ME, Gallarate M. (2004). Deformable liposomes for dermal administration of methotrexate. Int J Pharm 270:119-125.
27. Verma DD, Verma S, Blume G, Fahr A. (2003a). Liposomes increase skin penetration of entrapped and nonentrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study. Eur J Pharm Biopharm 55:271-277.
28. Verma DD, Verma S, Blume G, Fahr A. (2003b). Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm 258:141-151.
29. Walde P, Ichikawa S. (2001). Enzymes inside lipid vesicles: preparation, reactivity, and applications. Biomol Eng 18:143-177.